Glaucoma

Individuals with a high polygenic risk were more likely to experience rapid structural and functional progression in early-stage glaucoma, despite receiving intensive treatment, researchers reported in JAMA Ophthalmology.

Optometrists should adopt a holistic treatment approach and consider ocular, systemic and environmental risk factors that affect glaucoma development and progression, according to a review in the Journal of Current Glaucoma Practice.

The combination of low diastolic blood pressure and high IOP in patients with moderate to advanced glaucoma was associated with faster ganglion cell complex thinning rates, according to a study.

In this Healio Video Perspective, Nathan M. Radcliffe, MD, outlines why MicroPulse transscleral laser therapy is a viable option for patients who are not suitable for or do not want traditional glaucoma surgery.

In this Healio Video Perspective from the American Glaucoma Society meeting, Thomas W. Samuelson, MD, discusses positive safety and efficacy data for the ViaLase femtosecond laser image-guided high-precision trabeculotomy treatment.

Researchers have identified significant associations between intracranial pressure, translaminar pressure difference and visual field parameters in patients with normal-tension glaucoma, according to a study published in Diagnostics.

In this Healio Video Perspective from the EnVision Summit, Constance O. Okeke, MD, MSCE, discusses the mechanism of action and efficacy of Vyzulta to treat glaucoma.

Glaukos submitted a new drug application to the FDA for the iDose TR, a microinvasive intraocular implant designed to continuously deliver a travoprost formulation for the treatment of glaucoma.

TAMPA, Fla. — In this Healio Video Perspective from the Telling It Like It Is meeting, Robert J. Noecker, MD, MBA, discusses advantages that the TrabEx Pro offers for performing goniotomy.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Joel M. Solano, MD, CEO of eyecbetter, discusses offerings from the company.